SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001557142-20-000040
Filing Date
2020-06-05
Accepted
2020-06-05 16:16:58
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 kdmn-20200605xs3.htm S-3 628144
2 EX-5.1 kdmn-20200605xex5_1.htm EX-5.1 54870
3 EX-23.1 kdmn-20200605xex23_1.htm EX-23.1 10231
4 GRAPHIC kdmn-20200605xex5_1g001.jpg GRAPHIC 5690
5 GRAPHIC kdmn-20200605xex5_1g002.jpg GRAPHIC 2640
6 GRAPHIC kdmn-20200605xex5_1g003.jpg GRAPHIC 6147
7 GRAPHIC kdmn-20200605xs3g001.jpg GRAPHIC 6593
8 GRAPHIC kdmn-20200605xs3g002.jpg GRAPHIC 13455
9 GRAPHIC kdmn-20200605xs3g003.jpg GRAPHIC 4016
10 GRAPHIC kdmn-20200605xs3g004.jpg GRAPHIC 3574
  Complete submission text file 0001557142-20-000040.txt   753408
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-238969 | Film No.: 20946515
SIC: 2834 Pharmaceutical Preparations